OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 69 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,633,835 | +99.9% | 4,504,764 | +46.2% | 3.24% | +108.1% |
| Q2 2023 | $27,830,460 | +260119.4% | 3,082,000 | 0.0% | 1.56% | +121.4% |
| Q1 2023 | $10,695 | +109.7% | 3,082,000 | +48.0% | 0.70% | +106.5% |
| Q4 2022 | $5,101 | -99.9% | 2,082,000 | 0.0% | 0.34% | -15.2% |
| Q3 2022 | $5,746,000 | -32.2% | 2,082,000 | 0.0% | 0.40% | -37.3% |
| Q2 2022 | $8,474,000 | -4.5% | 2,082,000 | 0.0% | 0.64% | -5.9% |
| Q1 2022 | $8,869,000 | -56.3% | 2,082,000 | -4.0% | 0.68% | -43.6% |
| Q4 2021 | $20,310,000 | -76.0% | 2,169,871 | -29.4% | 1.21% | -64.9% |
| Q3 2021 | $84,705,000 | -1.5% | 3,073,485 | 0.0% | 3.44% | +17.8% |
| Q2 2021 | $85,996,000 | -18.2% | 3,073,485 | -3.8% | 2.92% | +24.8% |
| Q1 2021 | $105,084,000 | -29.1% | 3,195,544 | 0.0% | 2.34% | -33.6% |
| Q4 2020 | $148,169,000 | – | 3,195,544 | – | 3.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |